Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
37.6M
-
Shares change
-
-579K
-
Total reported value, excl. options
-
$145M
-
Value change
-
-$6.2M
-
Put/Call ratio
-
0.85
-
Number of buys
-
108
-
Number of sells
-
-71
-
Price
-
$3.87
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2025
245 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q2 2025.
Altimmune, Inc. - Common Stock (ALT) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.6M shares
of 80.7M outstanding shares and own 46.58% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.37M shares), VANGUARD GROUP INC (5.17M shares), STATE STREET CORP (2.75M shares), TANG CAPITAL MANAGEMENT LLC (2.75M shares), GEODE CAPITAL MANAGEMENT, LLC (1.93M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.62M shares), Knoll Capital Management, LLC (1.12M shares), Caption Management, LLC (981K shares), FEDERATED HERMES, INC. (915K shares), and UBS Group AG (887K shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.